Core Scientific CORZ
$11.33 −$2.03 (-15.19%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $11.75 +3.74%
Open$12.93
Prev close$13.36
Day range$11.26 – $12.99
Volume22.28M
Market cap$3.65B
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±7.0%last 11 reports
Closed higher7 of 1164% of the time
Best reaction+14.9%
Worst reaction-10.8%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 5 Nov 2026 | Pre Market | ±10.2% | -10.82% | Bigger than priced |
| 2026/Q2 | 28 Jul 2026 | Pre Market | ±8.4% | +0.02% | Within range |
| 2026/Q1 | 6 May 2026 | After Market | ±10.0% | -9.22% | Within range |
| 2025/Q4 | 2 Mar 2026 | After Market | ±16.4% | -7.22% | Within range |
| 2025/Q3 | 24 Oct 2025 | After Market | ±8.9% | +2.74% | Within range |
| 2025/Q2 | 8 Aug 2025 | After Market | ±11.2% | +0.83% | Within range |
| 2025/Q1 | 7 May 2025 | After Market | ±11.4% | +6.18% | Within range |
| 2024/Q4 | 26 Feb 2025 | After Market | ±13.4% | +6.89% | Within range |
| 2024/Q3 | 6 Nov 2024 | After Market | ±7.5% | +14.86% | Bigger than priced |
| 2024/Q1 | 8 May 2024 | After Market | ±17.6% | +12.07% | Within range |
| 2023/Q4 | 12 Mar 2024 | After Market | ±21.6% | -6.21% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$232.87M+187.1% YoY
Operating profit$79.21M+245.4% YoY
Net profit$1.18B+918.0% YoY
Diluted EPS$0.47+204.4% YoY
Free cash flow-$475.44M-321.8% YoY
Operating cash flow$65.29M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin41.2%
Operating margin-11.4%
Net margin-20.1%
Return on assets-2.9%
Current ratio0.67
Liabilities / assets118.4%
Cash & investments$803.94M
Total debt$4.30B
Net cash (debt)-$3.50B
No comments yet — be the first to weigh in on CORZ.
Sign in to join the discussion.